Kailasam Rajagopal, Palin Christopher A, Hogue Charles W
Division of Cardiothoracic Anesthesia, Department of Anesthesiology, Washington University School of Medicine, St Louis, MO 63110-1093, USA.
Semin Cardiothorac Vasc Anesth. 2005 Mar;9(1):77-85. doi: 10.1177/108925320500900108.
A number of advances in surgical and anesthetic techniques have reduced the risk for patients undergoing cardiac surgery. However, postoperative atrial fibrillation remains common, with an incidence ranging between 25% and 40%. It is associated with an increased incidence of congestive heart failure, renal insufficiency, and stroke that prolongs hospitalization and increases rates of readmission after discharge. Consequently, there has been great interest in strategies to prevent this arrhythmia. When both safety and efficacy are considered, the available evidence to date suggests that only beta-blockers can be recommended for the prevention of atrial fibrillation after cardiac surgery. Other treatments might be considered on an individual basis after careful consideration of the patient's potential for side effects.
外科手术和麻醉技术的一些进步降低了心脏手术患者的风险。然而，术后房颤仍然很常见，发生率在25%至40%之间。它与充血性心力衰竭、肾功能不全和中风的发生率增加有关，这会延长住院时间并增加出院后再次入院的几率。因此，人们对预防这种心律失常的策略非常感兴趣。当考虑到安全性和有效性时，迄今为止的现有证据表明，仅可推荐使用β受体阻滞剂来预防心脏手术后的房颤。在仔细考虑患者的副作用可能性后，可根据个体情况考虑其他治疗方法。
